Atlas Trials

Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

Clinical trial NCT03084965 · COMPLETED

Trial details

NCT number
NCT03084965
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Type II Diabetes Mellitus
Start date
2017-05-12
Primary completion
2018-03-02
Enrollment
1987

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.